{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:19:39Z","timestamp":1791821979468,"version":"4.3.4"},"reference-count":427,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["UHB12268"],"award-info":[{"award-number":["UHB12268"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2025-I2M-C"],"award-info":[{"award-number":["2025-I2M-C"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["T-B-010"],"award-info":[{"award-number":["T-B-010"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271112"],"award-info":[{"award-number":["82271112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301241"],"award-info":[{"award-number":["82301241"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.preteyeres.2025.101414","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T10:29:35Z","timestamp":1763029775000},"page":"101414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Polypoidal choroidal vasculopathy: In-depth insights and promising future directions"],"prefix":"10.1016","volume":"110","author":[{"given":"Zuyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SriniVas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemmy","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Loewenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzhen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nien","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paisan","family":"Ruamviboonsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2025.101414_bib1","unstructured":"Abraham, A.M., Shephali Patel, O., FAAO, M., Kalberer, D., FAAO, O., The many faces of polypoidal choroidal vasculopathy: a teaching case report. Optom. Educ. 50.."},{"key":"10.1016\/j.preteyeres.2025.101414_bib2","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4103\/njcp.njcp_682_20","article-title":"Polypoidal choroidal vasculopathy amongst Nigerians; A multicenter study","volume":"24","author":"Adenuga","year":"2021","journal-title":"Niger. J. Clin. Pract."},{"key":"10.1016\/j.preteyeres.2025.101414_bib3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/IAE.0000000000000157","article-title":"Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection","volume":"34","author":"Agawa","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1167\/iovs.18-24387","article-title":"Cytokine profiling in patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"60","author":"Agrawal","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/ceo.14305","article-title":"Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians","volume":"51","author":"Airaldi","year":"2023","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/IAE.0b013e31816577cb","article-title":"Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy","volume":"28","author":"Akaza","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/0974-9233.52000","article-title":"Idiopathic polypoidal choroidal vasculopathy in a young man: case report and literature review","volume":"15","author":"Al-Rashaed","year":"2008","journal-title":"Middle East Afr. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2020.105460","article-title":"Development of an automated system for the detection of genotype in polypoidal choroidal vasculopathy using retinal image phenotype","volume":"192","author":"Alagappan","year":"2020","journal-title":"Comput. Methods Progr. Biomed."},{"key":"10.1016\/j.preteyeres.2025.101414_bib9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00417-022-05861-w","article-title":"Association of HERPUD1 genetic variant rs2217332 with age-related macular degeneration and polypoidal choroidal vasculopathy in an Indian cohort","volume":"261","author":"Alagappan","year":"2023","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ajo.2014.12.012","article-title":"En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography","volume":"159","author":"Alasil","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4103\/0301-4738.67052","article-title":"Clinical features, management and visual outcome of polypoidal choroidal vasculopathy in Indian patients","volume":"58","author":"Anantharaman","year":"2010","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4103\/ijo.IJO_1136_17","article-title":"Polypoidal choroidal vasculopathy: pearls in diagnosis and management","volume":"66","author":"Anantharaman","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3928\/23258160-20181002-02","article-title":"Characteristics of polypoidal choroidal vasculopathy in OCT angiography in Latin American patients","volume":"49","author":"Arias","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/17434440.2018.1548932","article-title":"Optical coherence tomography angiography (OCTA) flow speed mapping technology for retinal diseases","volume":"15","author":"Arya","year":"2018","journal-title":"Expet Rev. Med. Dev."},{"key":"10.1016\/j.preteyeres.2025.101414_bib15","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1038\/s41598-020-65346-w","article-title":"Association between pachychoroid and long-term treatment outcomes of photodynamic therapy with intravitreal ranibizumab for polypoidal choroidal vasculopathy","volume":"10","author":"Azuma","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib16","article-title":"Ultra-widefield indocyanine green angiography reveals patterns of choroidal venous insufficiency influencing pachychoroid disease","volume":"63","author":"Bacci","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib17","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1038\/s41598-019-42052-w","article-title":"Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid","volume":"9","author":"Baek","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000000774","article-title":"Polypoidal choroidal vasculopathy: a distinct disease or manifestation of many?","volume":"36","author":"Balaratnasingam","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100586","article-title":"Safety and tolerability of suprachoroidal axitinib injectable suspension, for neovascular age-related macular degeneration; phase I\/IIa open-label, dose-escalation trial","volume":"5","author":"Barakat","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.preteyeres.2025.101414_bib20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jamaophthalmol.2019.0449","article-title":"Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using swept-source optical coherence tomographic angiography","volume":"137","author":"Bo","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ophtha.2022.09.013","article-title":"Progression of polypoidal lesions associated with exudative recurrence in polypoidal choroidal vasculopathy","volume":"130","author":"Bo","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib22","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.1111\/aos.14683","article-title":"Pachychoroid spectrum disease","volume":"99","author":"Borooah","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/ICB.0000000000001170","article-title":"Central serous chorioretinopathy mimicking idiopathic uveal effusion syndrome","volume":"17","author":"Boulanger","year":"2023","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107754","article-title":"Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: review of the pre-clinical and clinical evidence","volume":"187","author":"Bousquet","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101414_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10384-007-0498-2","article-title":"Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients","volume":"52","author":"Byeon","year":"2008","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/IAE.0b013e318188c839","article-title":"A classification system for polypoidal choroidal vasculopathy","volume":"29","author":"Cackett","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ophtha.2010.09.026","article-title":"Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons","volume":"118","author":"Cackett","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2018.05.005","article-title":"Color fundus photography, optical coherence tomography, and fluorescein angiography in diagnosing polypoidal choroidal vasculopathy","volume":"192","author":"Chaikitmongkol","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaophthalmol.2019.0565","article-title":"Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy","volume":"137","author":"Chaikitmongkol","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/APO.0000000000000445","article-title":"Treat-and-Extend regimens for the management of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy: consensus and recommendations from the Asia-Pacific vitreo-retina society","volume":"10","author":"Chaikitmongkol","year":"2021","journal-title":"Asia-Pacific Journal of Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.oret.2021.03.012","article-title":"Timing of complete polypoidal regression after intravitreous aflibercept treatments in polypoidal choroidal vasculopathy","volume":"6","author":"Chaikitmongkol","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib32","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(13)61501-9","article-title":"Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial","volume":"382","author":"Chakravarthy","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2025.101414_bib33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/IAE.0000000000001702","article-title":"Polypoidal choroidal vasculopathy upon optical coherence tomographic angiography","volume":"38","author":"Chan","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib34","article-title":"KSI-301: antibody biopolymer conjugate in retinal disorders","volume":"13","author":"Chandrasekaran","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib35","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/IAE.0000000000002583","article-title":"Difference between pachychoroid and NONPACHYCHOROID polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy","volume":"40","author":"Chang","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3341\/kjo.2016.30.3.198","article-title":"Optical coherence tomography-based diagnosis of polypoidal choroidal vasculopathy in Korean patients","volume":"30","author":"Chang","year":"2016","journal-title":"Kor. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib37","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00417-015-3173-1","article-title":"Polypoidal choroidal vasculopathy in patients aged less than 50 years: characteristics and 6-month treatment outcome","volume":"254","author":"Chang","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib38","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41433-021-01856-9","article-title":"Real-world cost-effectiveness of anti-VEGF monotherapy and combination therapy for the treatment of polypoidal choroidal vasculopathy","volume":"36","author":"Chay","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib39","first-page":"816","article-title":"Genetic associations in polypoidal choroidal vasculopathy: a systematic review and meta-analysis","volume":"18","author":"Chen","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2025.101414_bib40","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1167\/iovs.IOVS-15-18677","article-title":"Identification of PGF as a new gene for neovascular age-related macular degeneration in a Chinese population","volume":"57","author":"Chen","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib41","first-page":"1588","article-title":"Choroid changes in vortex vein-occluded monkeys","volume":"11","author":"Chen","year":"2018","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jfma.2019.04.012","article-title":"Management of polypoidal choroidal vasculopathy: experts consensus in Taiwan","volume":"119","author":"Chen","year":"2020","journal-title":"Journal of the Formosan Medical Association = Taiwan yi zhi"},{"key":"10.1016\/j.preteyeres.2025.101414_bib43","article-title":"Different morphology of branching neovascular network in polypoidal choroidal vasculopathy: a swept-source optical coherence tomography angiography study","volume":"12","author":"Chen","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib44","first-page":"77","article-title":"Chinese guideline on the management of polypoidal choroidal vasculopathy (2022)","volume":"38","author":"Chen","year":"2023","journal-title":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih"},{"key":"10.1016\/j.preteyeres.2025.101414_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2023.100003","article-title":"Genetic associations of central serous chorioretinopathy subtypes, neovascular age-related macular degeneration, and polypoidal choroidal vasculopathy","volume":"13","author":"Chen","year":"2024","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib46","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IAE.0b013e3181f84fdf","article-title":"One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy","volume":"31","author":"Cheng","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110818","article-title":"Hyperhomocysteinemia in patients with polypoidal choroidal vasculopathy: a case control study","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib48","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1038\/ncomms7063","article-title":"New loci and coding variants confer risk for age-related macular degeneration in East Asians","volume":"6","author":"Cheng","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101414_bib49","article-title":"Development and validation of optical coherence tomography (OCT) and OCT angiography prediction model for short-term vitreous haemorrhage secondary to polypoidal choroidal vasculopathy","author":"Cheng","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib50","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00417-015-2933-2","article-title":"The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients","volume":"253","author":"Cheung","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib51","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/IAE.0000000000001391","article-title":"Characterization and differentiation of polypoidal choroidal vasculopathy using swept source optical coherence tomography angiography","volume":"37","author":"Cheung","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib52","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.oret.2018.06.014","article-title":"Association between choroidal thickness and drusen subtypes in age-related macular degeneration","volume":"2","author":"Cheung","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib53","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management","volume":"125","author":"Cheung","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib54","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/IAE.0000000000002228","article-title":"Improved detection and diagnosis of polypoidal choroidal vasculopathy using a combination of optical coherence tomography and optical coherence tomography angiography","volume":"39","author":"Cheung","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib55","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","article-title":"Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the Asia-Pacific ocular imaging society PCV workgroup","volume":"128","author":"Cheung","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib56","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/IAE.0000000000002902","article-title":"Ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: predictors of visual and anatomical response in the EVEREST II study","volume":"41","author":"Cheung","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib57","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41433-024-03253-4","article-title":"Pachychoroid disease: review and update","volume":"39","author":"Cheung","year":"2025","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib58","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jamaophthalmol.2017.4360","article-title":"Optical coherence tomography angiography for assessment of the 3-Dimensional structures of polypoidal choroidal vasculopathy","volume":"135","author":"Chi","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib59","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/s41598-021-82316-y","article-title":"Systematic review with network meta-analysis of antivascular endothelial growth factor use in managing polypoidal choroidal vasculopathy","volume":"11","author":"Chi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2018.03.001","article-title":"The suprachoroidal space as a route of administration to the posterior segment of the eye","volume":"126","author":"Chiang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2025.101414_bib61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3341\/kjo.2012.26.3.157","article-title":"Short-term effectiveness of intravitreal bevacizumab vs. ranibizumab injections for patients with polypoidal choroidal vasculopathy","volume":"26","author":"Cho","year":"2012","journal-title":"Kor. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib62","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/eye.2011.324","article-title":"Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathy","volume":"26","author":"Cho","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2016.02.019","article-title":"Intravitreal aflibercept and ranibizumab injections for polypoidal choroidal vasculopathy","volume":"165","author":"Cho","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2016.06.014","article-title":"Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal vasculopathy","volume":"169","author":"Cho","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib65","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/IAE.0000000000002384","article-title":"Posttreatment polyp regression and risk of massive submacular hemorrhage in eyes with polypoidal choroidal vasculopathy","volume":"40","author":"Cho","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib66","doi-asserted-by":"crossref","first-page":"e706","DOI":"10.1111\/aos.14676","article-title":"Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age-related macular degeneration","volume":"99","author":"Cho","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1204026","article-title":"Discontinuation of treatment and retreatment of neovascular age-related macular degeneration in the real-world: Bundang AMD cohort study report 5","volume":"10","author":"Cho","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib68","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.18240\/ijo.2021.09.16","article-title":"Long-term outcomes of focal laser photocoagulation for the treatment of polypoidal choroidal vasculopathy","volume":"14","author":"Choe","year":"2021","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib69","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41598-023-28385-7","article-title":"Aqueous microRNA profiling in age-related macular degeneration and polypoidal choroidal vasculopathy by next-generation sequencing","volume":"13","author":"Choi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib70","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000004057","article-title":"Imaging and clinical features of pulsatile polypoidal choroidal vasculopathy","author":"Choi","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib71","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000004590","article-title":"Regional variability in choroidal vascularity index and association with intervortex anastomoses in polypoidal choroidal vasculopathy","author":"Chong","year":"2025","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib72","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/jamaophthalmol.2025.0250","article-title":"Aflibercept with vs without reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial","volume":"143","author":"Chong","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib73","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.oret.2021.04.002","article-title":"Non-ICGA treatment criteria for suboptimal Anti-VEGF response for polypoidal choroidal vasculopathy: APOIS PCV workgroup report 2","volume":"5","author":"Chong Teo","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib74","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1038\/s41598-021-86526-2","article-title":"Deep learning and ensemble stacking technique for differentiating polypoidal choroidal vasculopathy from neovascular age-related macular degeneration","volume":"11","author":"Chou","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib75","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ophtha.2010.09.012","article-title":"Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration","volume":"118","author":"Chung","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib76","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcjo.2016.02.012","article-title":"Hypertension as a risk factor for recurrent subretinal hemorrhage in polypoidal choroidal vasculopathy","volume":"51","author":"Chung","year":"2016","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.survophthal.2003.10.007","article-title":"Polypoidal choroidal vasculopathy","volume":"49","author":"Ciardella","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101323","article-title":"Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration","volume":"104","author":"Corydon","year":"2025","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101414_bib79","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.4114","article-title":"Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration","volume":"36","author":"da Cruz","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib80","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/IAE.0000000000000742","article-title":"EN face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography","volume":"36","author":"Dansingani","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib81","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1016\/j.ophtha.2016.06.060","article-title":"Risk alleles associated with neovascularization in a pachychoroid phenotype","volume":"123","author":"Dansingani","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/ceo.13114","article-title":"Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of 'expanded spectra' - a review","volume":"46","author":"Dansingani","year":"2018","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib83","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1097\/IAE.0000000000000206","article-title":"Polypoidal choroidal vasculopathy in white patients","volume":"34","author":"Davis","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib84","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/IAE.0000000000002139","article-title":"Sensitivity and Specificity of Detecting Polypoidal Choroidal Vasculopathy with En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography","volume":"39","author":"de Carlo","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib85","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ajo.2014.08.025","article-title":"Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy","volume":"158","author":"De Salvo","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib86","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1038\/s41433-024-03221-y","article-title":"Real world treatment outcomes in polypoidal choroidal vasculopathy in a Caucasian population of British ethnicity","volume":"38","author":"De Salvo","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib87","doi-asserted-by":"crossref","first-page":"13968","DOI":"10.18632\/aging.203006","article-title":"Untargeted metabolomics for uncovering plasma biological markers of wet age-related macular degeneration","volume":"13","author":"Deng","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib88","article-title":"A study of the relationship between cytokine levels and the response to anti-VEGF therapy in polypoid choroidal vasculopathy with different choroidal thicknesses","volume":"14","author":"Dong","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib89","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib90","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101414_bib91","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1091\/mbc.e08-11-1136","article-title":"Faciogenital dysplasia protein (FGD1) regulates export of cargo proteins from the golgi complex via Cdc42 activation","volume":"20","author":"Egorov","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.preteyeres.2025.101414_bib92","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.survophthal.2009.05.003","article-title":"Uveal effusion syndrome","volume":"55","author":"Elagouz","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib93","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pdpdt.2019.09.005","article-title":"The effect of the smoking on choroidal thickness, central macular vascular and optic disc perfusion","volume":"28","author":"Eri\u015f","year":"2019","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.preteyeres.2025.101414_bib94","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bjophthalmol-2018-312431","article-title":"Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients","volume":"103","author":"Ersoz","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib95","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcma.2013.10.012","article-title":"Comparison of the effect of reduced-fluence photodynamic therapy with intravitreal bevacizumab and standard-fluence alone for polypoidal choroidal vasculopathy","volume":"77","author":"Fan","year":"2014","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.preteyeres.2025.101414_bib96","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/jhg.2017.83","article-title":"Shared genetic variants for polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration in East Asians","volume":"62","author":"Fan","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2025.101414_bib97","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/2474126420946599","article-title":"Cost and outcomes analysis of polypoidal choroidal vasculopathy (aneurysmal type 1 neovascularization) treatment strategies","volume":"5","author":"Feng","year":"2021","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.preteyeres.2025.101414_bib98","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.oret.2019.10.019","article-title":"Real-world treatment outcomes of age-related macular degeneration and polypoidal choroidal vasculopathy in Asians","volume":"4","author":"Fenner","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib99","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.oret.2021.09.009","article-title":"Prevalence of polypoidal choroidal vasculopathy using Non-indocyanine green angiography-based Criteria","volume":"6","author":"Fenner","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","article-title":"Age-Related macular degeneration: a review","volume":"331","author":"Fleckenstein","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.preteyeres.2025.101414_bib101","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/ng.170","article-title":"Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA","volume":"40","author":"Fritsche","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2025.101414_bib102","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1097\/IAE.0000000000002760","article-title":"Diagnostic characteristics of polypoidal choroidal vasculopathy based on B-scan swept-source optical coherence tomography angiography and its interrater agreement compared with indocyanine green angiography","volume":"40","author":"Fujita","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib103","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/08820538.2018.1506483","article-title":"Prevalence and risk factors for polypoidal choroidal vasculopathy in a general Japanese population: the hisayama study","volume":"33","author":"Fujiwara","year":"2018","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48494-6","article-title":"Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration","volume":"9","author":"Fukuda","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082459","article-title":"Title: pachydrusen in fellow eyes predict response to aflibercept monotherapy in patients with polypoidal choroidal vasculopathy","volume":"9","author":"Fukuda","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091164","article-title":"Comparison of outcomes between 3 monthly brolucizumab and aflibercept injections for polypoidal choroidal vasculopathy","volume":"9","author":"Fukuda","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.preteyeres.2025.101414_bib107","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s10384-023-00999-4","article-title":"Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy","volume":"67","author":"Fukuda","year":"2023","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib108","article-title":"Association of flow signals within polyps on optical coherence tomography angiography with treatment responses after combination therapy for polypoidal choroidal vasculopathy","author":"Fukuyama","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib109","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/IAE.0000000000003395","article-title":"Association of flow signals within polyps on optical coherence tomography angiography with treatment responses after combination therapy for polypoidal choroidal vasculopathy","volume":"42","author":"Fukuyama","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib110","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41598-023-31649-x","article-title":"Clinical variations of polypoidal choroidal vasculopathy: a cohort study from Japan and the USA","volume":"13","author":"Fukuyama","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib111","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/IAE.0b013e3182680a66","article-title":"Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration","volume":"32","author":"Fung","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib112","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ophtha.2023.04.014","article-title":"Surgery, tissue plasminogen activator, antiangiogenic agents, and age-related macular degeneration study: a randomized controlled trial for submacular hemorrhage secondary to age-related macular degeneration","volume":"130","author":"Gabrielle","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib113","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajo.2012.08.002","article-title":"Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy","volume":"155","author":"Gemmy Cheung","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib114","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bjo.2007.122283","article-title":"Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy","volume":"92","author":"Gomi","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib115","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1167\/iovs.12-10870","article-title":"Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the alpha6(IV)NC1 collagen fragment","volume":"54","author":"Gunda","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib116","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101414_bib117","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/s41598-022-05903-7","article-title":"Classifying neovascular age-related macular degeneration with a deep convolutional neural network based on optical coherence tomography images","volume":"12","author":"Han","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib118","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/IAE.0000000000000767","article-title":"ONE-YEAR results of intravitreal aflibercept for polypoidal choroidal vasculopathy","volume":"36","author":"Hara","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.896907","article-title":"Senolytics in the treatment of diabetic retinopathy","volume":"13","author":"Hassan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib120","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.oret.2019.06.013","article-title":"Efficacy of photodynamic therapy for polypoidal choroidal vasculopathy associated with and without pachychoroid phenotypes","volume":"3","author":"Hata","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib121","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/bjophthalmol-2013-303444","article-title":"Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response","volume":"98","author":"Hatz","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib122","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1167\/iovs.10-5554","article-title":"CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation","volume":"51","author":"Hayashi","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib123","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2025.101414_bib124","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ophtha.2021.09.016","article-title":"Archway randomized phase 3 trial of the port delivery system with ranibizumab for neovascular age-related macular degeneration","volume":"129","author":"Holekamp","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000355488","article-title":"Polypoidal choroidal vasculopathy: clinical features and genetic predisposition","volume":"231","author":"Honda","year":"2014","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2025.101414_bib126","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/aos.13049","article-title":"Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis","volume":"94","author":"Hong","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib127","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41598-024-51628-0","article-title":"Predicting treatment outcomes of intravitreal brolucizumab for polypoidal choroidal vasculopathy through noninvasive assessment of polypoidal lesion blood flow with optical coherence tomography angiography","volume":"14","author":"Hoshino","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib128","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1073\/pnas.1802212115","article-title":"CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy","volume":"115","author":"Hosoda","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2025.101414_bib129","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/bjophthalmol-2014-305275","article-title":"Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy","volume":"99","author":"Hosokawa","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib130","article-title":"The features of inflammation factors concentrations in aqueous humor of polypoidal choroidal vasculopathy","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib131","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1167\/iovs.13-13437","article-title":"Different hereditary contribution of the CFH gene between polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese Han people","volume":"55","author":"Huang","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib132","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ng.3546","article-title":"A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy","volume":"48","author":"Huang","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.preteyeres.2025.101414_bib133","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/s41433-022-02251-8","article-title":"Characteristics and treatment response of polypoidal choroidal vasculopathy in highly myopic eyes","volume":"37","author":"Huang","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib134","doi-asserted-by":"crossref","first-page":"9275","DOI":"10.1038\/s41598-021-88543-7","article-title":"Distinguishing retinal angiomatous proliferation from polypoidal choroidal vasculopathy with a deep neural network based on optical coherence tomography","volume":"11","author":"Hwang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib135","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41433-022-02222-z","article-title":"Na\u00efve subretinal haemorrhage due to neovascular age-related macular degeneration. Pneumatic displacement, subretinal air, and tissue plasminogen activator: subretinal vs intravitreal aflibercept-the native study","volume":"37","author":"Iglicki","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib136","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41433-023-02676-9","article-title":"Comparison of subretinal aflibercept vs ranibizumab vs bevacizumab in the context of PPV, pneumatic displacement with subretinal air and subretinal tPA in na\u00efve submacular haemorrhage secondary to nAMD. \"The Submarine Study\"","volume":"38","author":"Iglicki","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib137","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00417-014-2707-2","article-title":"Short-term efficacy of intravitreal aflibercept for patients with treatment-na\u00efve polypoidal choroidal vasculopathy","volume":"253","author":"Ijiri","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib138","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/eye.2013.179","article-title":"Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy","volume":"27","author":"Inoue","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.preteyeres.2025.101414_bib139","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/IAE.0000000000000229","article-title":"Short-term efficacy of intravitreal aflibercept in treatment-naive patients with polypoidal choroidal vasculopathy","volume":"34","author":"Inoue","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib140","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1097\/IAE.0000000000000777","article-title":"Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization","volume":"35","author":"Inoue","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib141","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/IAE.0000000000000933","article-title":"Aflibercept for polypoidal choroidal vasculopathy: as needed versus fixed interval dosing","volume":"36","author":"Inoue","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib142","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000368561","article-title":"Stereotactic radiotherapy for polypoidal choroidal vasculopathy: a pilot study","volume":"233","author":"Introini","year":"2015","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2025.101414_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235213","article-title":"Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathy","volume":"15","author":"Ito","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib144","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1038\/s41598-022-12216-2","article-title":"One-year outcomes of intravitreal brolucizumab injections in patients with polypoidal choroidal vasculopathy","volume":"12","author":"Ito","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/IAE.0000000000003264","article-title":"Optical coherence tomography angiography findings of classic choroidal neovascularization in polypoidal choroidal vasculopathy","volume":"42","author":"Izumi","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib146","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.ophtha.2013.02.016","article-title":"Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study","volume":"120","author":"Jackson","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib147","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ophtha.2014.07.043","article-title":"Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID study","volume":"122","author":"Jackson","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib148","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ophtha.2023.02.001","article-title":"A randomized controlled trial of OPT-302, a VEGF-C\/D inhibitor for neovascular age-related macular degeneration","volume":"130","author":"Jackson","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib149","first-page":"417","article-title":"[Criteria for diagnosis of polypoidal choroidal vasculopathy]","volume":"109","year":"2005","journal-title":"Nippon. Ganka Gakkai Zasshi"},{"key":"10.1016\/j.preteyeres.2025.101414_bib150","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0b013e318276e096","article-title":"Adjusted retreatment of polypoidal choroidal vasculopathy after combination therapy: results at 3 years","volume":"33","author":"Jeon","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib151","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103088","article-title":"Management of a submacular hemorrhage secondary to age-related macular degeneration: a comparison of three treatment modalities","volume":"9","author":"Jeong","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib152","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1364\/OE.20.004710","article-title":"Split-spectrum amplitude-decorrelation angiography with optical coherence tomography","volume":"20","author":"Jia","year":"2012","journal-title":"Opt. Express"},{"key":"10.1016\/j.preteyeres.2025.101414_bib153","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcjo.2021.09.008","article-title":"Subfoveal choroidal thickness as a potential predictor of treatment response after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy","volume":"58","author":"Jim\u00e9nez-Santos","year":"2023","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib154","first-page":"13928","article-title":"Evidence of a novel gene HERPUD1 in polypoidal choroidal vasculopathy","volume":"8","author":"Jin","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93899-x","article-title":"Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"11","author":"Jin","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib156","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1167\/iovs.12-9619","article-title":"Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"53","author":"Jirarattanasopa","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib157","doi-asserted-by":"crossref","first-page":"14578","DOI":"10.1073\/pnas.1102853108","article-title":"Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice","volume":"108","author":"Jones","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2025.101414_bib158","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/bjophthalmol-2020-317537","article-title":"T and genetic variations between Asian and Caucasian polypoidal choroidal vasculopathy","volume":"105","author":"Jordan-Yu","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib159","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ophtha.2010.10.012","article-title":"Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population","volume":"118","author":"Kabasawa","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.oret.2021.09.012","article-title":"Laser photocoagulation for refractory polypoidal choroidal vasculopathy","volume":"6","author":"Kakihara","year":"2022","journal-title":"Ophthalmology Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib161","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1442-9071.2007.01554.x","article-title":"Polypoidal choroidal vasculopathy examined with en face optical coherence tomography","volume":"35","author":"Kameda","year":"2007","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib162","article-title":"Choriocapillaris structure in the fellow eye of neovascular age-related macular degeneration patients: an OCT angiography image averaging study","volume":"59","author":"Kamei","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib163","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/bjophthalmol-2020-317563","article-title":"Microvascular abnormalities and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD","volume":"106","author":"Katja","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib164","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.61.13.39","article-title":"Complement activation products and cytokines in pachychoroid neovasculopathy and neovascular age-related macular degeneration","volume":"61","author":"Kato","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100167","article-title":"Age-related maculopathy susceptibility 2 and complement factor H polymorphism and intraocular complement activation in neovascular age-related macular degeneration","volume":"2","author":"Kato","year":"2022","journal-title":"Ophthalmology science"},{"key":"10.1016\/j.preteyeres.2025.101414_bib166","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.ophtha.2006.12.021","article-title":"Elevated C-Reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration","volume":"114","author":"Kikuchi","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib167","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3928\/15428877-20090430-14","article-title":"Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy","volume":"40","author":"Kim","year":"2009","journal-title":"Ophthalmic Surg. Laser. Imag."},{"key":"10.1016\/j.preteyeres.2025.101414_bib168","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/eye.2017.126","article-title":"Submacular hemorrhage and grape-like polyp clusters: factors associated with reactivation of the lesion in polypoidal choroidal vasculopathy","volume":"31","author":"Kim","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib169","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ajo.2020.05.017","article-title":"A comparison study of polypoidal choroidal vasculopathy imaged with indocyanine green angiography and swept-source optical coherence tomography angiography","volume":"217","author":"Kim","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib170","article-title":"Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib171","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00417-020-05051-6","article-title":"Choroidal thickness profile and clinical outcomes in eyes with polypoidal choroidal vasculopathy","volume":"259","author":"Kim","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib172","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1111\/aos.16699","article-title":"Long-term efficacy and safety of brolucizumab in neovascular age-related macular degeneration: a multicentre retrospective real-world study","volume":"102","author":"Kim","year":"2024","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib173","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1007\/s00417-022-05687-6","article-title":"A new insight into pachychoroid diseases: remodeling of choroidal vasculature","volume":"260","author":"Kishi","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib174","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archopht.123.8.1149","article-title":"Choroidal infarction following photodynamic therapy with verteporfin","volume":"123","author":"Klais","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib175","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101414_bib176","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ophtha.2013.06.020","article-title":"Ranibizumab versus bevacizumab for neovascular age-related macular degeneration: results from the GEFAL noninferiority randomized trial","volume":"120","author":"Kodjikian","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib177","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib178","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/IAE.0b013e3182852446","article-title":"Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment","volume":"33","author":"Koh","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib179","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib180","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/bjophthalmol-2014-306432","article-title":"Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study","volume":"99","author":"Koizumi","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib181","first-page":"74","article-title":"Prospective evaluation of subretinal vessel location in polypoidal choroidal vasculopathy (PCV) and response of hemorrhagic and exudative PCV to high-dose antiangiogenic therapy (an American ophthalmological society thesis)","volume":"112","author":"Kokame","year":"2014","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.preteyeres.2025.101414_bib182","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.oret.2023.11.018","article-title":"Emerging importance of polypoidal choroidal vasculopathy","volume":"8","author":"Kokame","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib183","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bjo.2008.150029","article-title":"Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results","volume":"94","author":"Kokame","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib184","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000354072","article-title":"Polypoidal choroidal vasculopathy exudation and hemorrhage: results of monthly ranibizumab therapy at one year","volume":"231","author":"Kokame","year":"2014","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2025.101414_bib185","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ajo.2007.06.003","article-title":"LOC387715\/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population","volume":"144","author":"Kondo","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib186","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1167\/iovs.07-1145","article-title":"Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"49","author":"Kondo","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib187","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ophtha.2008.11.011","article-title":"Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy","volume":"116","author":"Kondo","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib188","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1167\/iovs.13-13111","article-title":"Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium","volume":"55","author":"Kumar","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib189","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.ajpath.2017.08.025","article-title":"Proteolytic degradation and inflammation play critical roles in polypoidal choroidal vasculopathy","volume":"187","author":"Kumar","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib190","article-title":"Polypoidal choroidal vasculopathy: a comprehensive clinical update","volume":"11","author":"Kumar","year":"2019","journal-title":"Ther Adv Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib191","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/ATVBAHA.111.244004","article-title":"FGD5 mediates proangiogenic action of vascular endothelial growth factor in human vascular endothelial cells","volume":"32","author":"Kurogane","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib192","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1442-9071.2004.00827.x","article-title":"Pathological features of surgically excised polypoidal choroidal vasculopathy membranes","volume":"32","author":"Kuroiwa","year":"2004","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib193","first-page":"650","article-title":"Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation","volume":"20","author":"Lafaut","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib194","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s004170000180","article-title":"Polypoidal choroidal vasculopathy in Caucasians","volume":"238","author":"Lafaut","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib195","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/bjo.2007.135103","article-title":"Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy","volume":"92","author":"Lai","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib196","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11185340","article-title":"Association of fundus autofluorescence abnormalities and pachydrusen in central serous chorioretinopathy and polypoidal choroidal vasculopathy","volume":"11","author":"Lai","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib197","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/IAE.0b013e3181d37486","article-title":"Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up","volume":"30","author":"Leal","year":"2010","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib198","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/IAE.0000000000002019","article-title":"Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: multimodal image study","volume":"39","author":"Lee","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib199","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/IAE.0000000000000498","article-title":"HALF-DOSE photodynamic therapy combined with bevacizumab for polypoidal choroidal vasculopathy","volume":"35","author":"Lee","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib200","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1167\/iovs.07-0860","article-title":"Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy","volume":"49","author":"Lee","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib201","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajo.2013.04.001","article-title":"Photodynamic therapy versus combination therapy in polypoidal choroidal vasculopathy: changes of aqueous vascular endothelial growth factor","volume":"156","author":"Lee","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib202","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00417-016-3489-5","article-title":"Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study","volume":"255","author":"Lee","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib203","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1167\/iovs.18-25018","article-title":"Changes in stromal and luminal areas of the choroid in pachychoroid diseases: insights into the pathophysiology of pachychoroid diseases","volume":"59","author":"Lee","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib204","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib205","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/IAE.0000000000002419","article-title":"Drusen subtypes and choroidal characteristics in asian eyes with typical neovascular age-related macular degeneration","volume":"40","author":"Lee","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib206","article-title":"Faricimab for polypoidal choroidal vasculopathy: week 16 results from the phase 3b\/4 SALWEEN trial","volume":"66","author":"Lee","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib207","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/IAE.0000000000000287","article-title":"PACHYCHOROID: an inherited condition?","volume":"35","author":"Lehmann","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib208","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1440-1797.2010.01373.x","article-title":"Review: complement and its regulatory proteins in kidney diseases","volume":"15","author":"Lesher","year":"2010","journal-title":"Nephrology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib209","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ophtha.2014.03.026","article-title":"Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study","volume":"121","author":"Li","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib210","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.ophtha.2014.06.016","article-title":"Polypoidal choroidal vasculopathy in adult Chinese: the Beijing eye study","volume":"121","author":"Li","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib211","article-title":"Analysis of the serum lipid profile in polypoidal choroidal vasculopathy","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib212","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1111\/aos.14588","article-title":"Two different treatment regimens of ranibizumab 0.5 mg for neovascular age-related macular degeneration with or without polypoidal choroidal vasculopathy in Chinese patients: results from the Phase IV, randomized, DRAGON study","volume":"99","author":"Li","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib213","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1111\/aos.15272","article-title":"The comparison of two different strategies of intravitreal conbercept for polypoidal choroidal vasculopathy in Chinese patients results from a 48-week randomized phase 4 study: STAR study","volume":"101","author":"Li","year":"2023","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib214","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/eye.2014.226","article-title":"FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"28","author":"Liang","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib215","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41433-020-0834-z","article-title":"Prevalence of polypoidal choroidal vasculopathy in Caucasian patients as estimated from optical coherence tomography signs","volume":"35","author":"Liew","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib216","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","article-title":"Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: the EVEREST II randomized clinical trial","volume":"138","author":"Lim","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib217","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/13816810.2010.544362","article-title":"Elastin rs2301995 polymorphism is not associated with polypoidal choroidal vasculopathy in caucasians","volume":"32","author":"Lima","year":"2011","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2025.101414_bib218","article-title":"Anti-angiogenic collagen IV-derived peptide target engagement with \u03b1(v)\u03b2(3) and \u03b1(5)\u03b2(1) in ocular neovascularization models","volume":"26","author":"Lima","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.preteyeres.2025.101414_bib219","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.survophthal.2024.12.006","article-title":"Enhancing anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy: a meta-analysis","volume":"70","author":"Lin","year":"2025","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib220","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ophtha.2012.10.003","article-title":"Associations of the C2-CFB-RDBP-SKIV2L locus with age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"120","author":"Liu","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib221","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ophtha.2013.10.042","article-title":"Genes in the high-density lipoprotein metabolic pathway in age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"121","author":"Liu","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib222","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/IAE.0000000000000794","article-title":"Distinguishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography","volume":"36","author":"Liu","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib223","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1021\/acs.jproteome.9b00574","article-title":"Serum metabolomics reveals personalized metabolic patterns for macular neovascular disease patient stratification","volume":"19","author":"Liu","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.preteyeres.2025.101414_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109160","article-title":"Analysis of the aqueous humor lipid profile in patients with polypoidal choroidal vasculopathy","volume":"222","author":"Liu","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101414_bib225","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00417-021-05525-1","article-title":"Clinicopathological study of the polypoidal lesions of polypoidal choroidal vasculopathy","volume":"260","author":"Liu","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib226","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.2147\/JIR.S417791","article-title":"Serum amyloid A 4 as a common marker of persistent inflammation in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"16","author":"Liu","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.preteyeres.2025.101414_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100292","article-title":"Joint multimodal deep learning-based automatic segmentation of indocyanine green angiography and OCT images for assessment of polypoidal choroidal vasculopathy biomarkers","volume":"3","author":"Loo","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.preteyeres.2025.101414_bib228","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/IAE.0000000000001872","article-title":"Prevalence of polypoidal choroidal vasculopathy in white patients with exudative age-related macular degeneration: systematic review and meta-analysis","volume":"38","author":"Lorentzen","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib229","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40123-023-00843-5","article-title":"Clinical trials and future outlooks of the port delivery system with ranibizumab: a narrative review","volume":"13","author":"Lowater","year":"2024","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.preteyeres.2025.101414_bib230","first-page":"89","article-title":"Present view in understanding of polypoidal choroidal vasculopathy","volume":"40","author":"Ma","year":"2024","journal-title":"Chinese Journal of Ocular Fundus Diseases"},{"key":"10.1016\/j.preteyeres.2025.101414_bib231","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1167\/iovs.16-20575","article-title":"Identification of ANGPT2 as a new gene for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in the Chinese and Japanese populations","volume":"58","author":"Ma","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib232","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/IAE.0000000000003130","article-title":"Sensitivity and specificity of multispectral imaging for polypoidal choroidal vasculopathy","volume":"41","author":"Ma","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib233","article-title":"Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography","volume":"11","author":"Ma","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105319","article-title":"Clinical explainable differential diagnosis of polypoidal choroidal vasculopathy and age-related macular degeneration using deep learning","volume":"143","author":"Ma","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib235","article-title":"Macular function evaluated by focal macular electroretinograms after reduced fluence photodynamic therapy in eyes with poplypoidal choroidal vasculopathy","volume":"52","author":"Machida","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib236","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.4103\/ijo.IJO_2905_21","article-title":"Choriocapillaris flow deficits in polypoidal choroidal vasculopathy using swept source optical coherence tomography angiography","volume":"70","author":"Mahalingam","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib237","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/IAE.0000000000001665","article-title":"Polypoidal choroidal vasculopathy associated with central serous chorioretinopathy: pachychoroid spectrum of diseases","volume":"38","author":"Manayath","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib238","doi-asserted-by":"crossref","DOI":"10.4103\/ijo.IJO_1081_19","article-title":"Safety of photodynamic therapy involving optic nerve head","volume":"68","author":"Manayath","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib239","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.973025","article-title":"Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"9","author":"Mao","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib240","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10528-016-9766-5","article-title":"Taq1B polymorphism of cholesteryl ester transfer Protein (CETP) and its effects on the serum lipid levels in Metabolic syndrome patients","volume":"54","author":"Maroufi","year":"2016","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.preteyeres.2025.101414_bib241","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Martin","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib242","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"Maruko","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib243","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00417-023-06241-8","article-title":"Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration","volume":"262","author":"Maruyama-Inoue","year":"2024","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib244","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237330","article-title":"Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results","volume":"15","author":"Matsubara","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib245","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00417-019-04284-4","article-title":"Clinical characteristics of pachydrusen in central serous chorioretinopathy","volume":"257","author":"Matsumoto","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib246","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95904-9","article-title":"Chronic choriocapillaris ischemia in dilated vortex vein region in pachychoroid neovasculopathy","volume":"11","author":"Matsumoto","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib247","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94412-0","article-title":"Pulsation of anastomotic vortex veins in pachychoroid spectrum diseases","volume":"11","author":"Matsumoto","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib248","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246115","article-title":"Choroidal congestion mouse model: could it serve as a pachychoroid model?","volume":"16","author":"Matsumoto","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib249","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1038\/s41598-022-10578-1","article-title":"One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-na\u00efve neovascular age-related macular degeneration with type 1 macular neovascularization","volume":"12","author":"Matsumoto","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274137","article-title":"Vortex vein congestion in the monkey eye: a possible animal model of pachychoroid","volume":"17","author":"Matsumoto","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib251","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1007\/s00417-023-06116-y","article-title":"Short-term outcomes of intravitreal faricimab for treatment-na\u00efve neovascular age-related macular degeneration","volume":"261","author":"Matsumoto","year":"2023","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100515","article-title":"Inversion of asymmetric vortex vein dilatation in pachychoroid spectrum diseases","volume":"4","author":"Matsumoto","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.preteyeres.2025.101414_bib253","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143924","article-title":"Effect of high-density lipoprotein metabolic pathway gene variations and risk factors on neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in China","volume":"10","author":"Meng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib254","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000533529","article-title":"Anti-vascular endothelial growth factor therapy regimens for polypoidal choroidal vasculopathy: a systematic review","volume":"246","author":"Mihalache","year":"2023","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2025.101414_bib255","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1167\/iovs.16-20969","article-title":"Comparison between spectral-domain and swept-source optical coherence tomography angiographic imaging of choroidal neovascularization","volume":"58","author":"Miller","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib256","doi-asserted-by":"crossref","DOI":"10.1038\/srep16204","article-title":"Pachychoroid neovasculopathy and age-related macular degeneration","volume":"5","author":"Miyake","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib257","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ophtha.2020.11.011","article-title":"Risk of inflammation, retinal vasculitis, and retinal occlusion-related events with brolucizumab: post hoc review of HAWK and HARRIER","volume":"128","author":"Mon\u00e9s","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib258","first-page":"379","article-title":"Impact of polyp regression on 2-year outcomes of intravitreal aflibercept injections: a treat-and-extend regimen for polypoidal choroidal vasculopathy","volume":"72","author":"Morizane-Hosokawa","year":"2018","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.preteyeres.2025.101414_bib259","doi-asserted-by":"crossref","first-page":"8747","DOI":"10.1038\/s41598-023-35759-4","article-title":"Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan","volume":"13","author":"Mukai","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib260","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18619-5","article-title":"Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy","volume":"12","author":"Mun","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib261","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ajo.2006.12.024","article-title":"Microrips of the retinal pigment epithelium in polypoidal choroidal vasculopathy","volume":"143","author":"Musashi","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib262","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47738-9","article-title":"Dynamic changes in choroidal conditions during anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy","volume":"9","author":"Nagai","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib263","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10384-003-0057-4","article-title":"Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy","volume":"48","author":"Nakajima","year":"2004","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib264","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1167\/iovs.09-4948","article-title":"Joint effect of cigarette smoking and CFH and LOC387715\/HTRA1 polymorphisms on polypoidal choroidal vasculopathy","volume":"51","author":"Nakanishi","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib265","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1167\/iovs.08-2134","article-title":"Clinicopathologic findings in polypoidal choroidal vasculopathy","volume":"49","author":"Nakashizuka","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib266","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1167\/iovs.11-8468","article-title":"Significance of C2\/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population","volume":"53","author":"Nakata","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib267","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1167\/iovs.13-11605","article-title":"Association between the cholesteryl ester transfer protein gene and polypoidal choroidal vasculopathy","volume":"54","author":"Nakata","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib268","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12886-020-01419-8","article-title":"Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy","volume":"20","author":"Ngo","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib269","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2016.01.011","article-title":"Choroidal neovascularization analyzed on ultrahigh-speed swept-source optical coherence tomography angiography compared to spectral-domain optical coherence tomography angiography","volume":"164","author":"Novais","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib270","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/bjophthalmol-2021-319090","article-title":"Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK","volume":"106","author":"Ogura","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib271","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ajo.2013.05.024","article-title":"Comparison of the effect of ranibizumab and verteporfin for polypoidal choroidal vasculopathy: 12-month LAPTOP study results","volume":"156","author":"Oishi","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib272","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ophtha.2013.12.037","article-title":"LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy","volume":"121","author":"Oishi","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib273","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ajo.2015.01.018","article-title":"One-year result of aflibercept treatment on age-related macular degeneration and predictive factors for visual outcome","volume":"159","author":"Oishi","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib274","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/IAE.0b013e3181884fbf","article-title":"Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography","volume":"29","author":"Ojima","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib275","first-page":"885","article-title":"[Experimental study on the development of collateral shunt vessels following anterior uveal circulatory disturbances in the rabbit eye. 2. Occlusion of the vortex veins]","volume":"89","author":"Okada","year":"1985","journal-title":"Nippon. Ganka Gakkai Zasshi"},{"key":"10.1016\/j.preteyeres.2025.101414_bib276","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1007\/s12325-022-02162-w","article-title":"Efficacy and safety of intravitreal aflibercept treat-and-extend regimens in the ALTAIR study: 96-week outcomes in the polypoidal choroidal vasculopathy subgroup","volume":"39","author":"Okada","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.preteyeres.2025.101414_bib277","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4103\/aam.aam_68_22","article-title":"Outcome of peripapillary polypoidal choroidal vasculopathy treatment using combination therapy intravitreal ranibizumab and thermal retinal laser photocoagulation","volume":"22","author":"Okonkwo","year":"2023","journal-title":"Ann. Afr. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib278","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/bjo.86.10.1093","article-title":"Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study","volume":"86","author":"Okubo","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib279","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/IAE.0000000000004509","article-title":"Fundus autofluorescence (FAF) alteration in polypoidal choroidal vasculopathy (PCV) and typical neovascular age related macular degeneration (tAMD)","volume":"45","author":"Ong","year":"2025","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000477448","article-title":"One-year outcomes following intravitreal aflibercept for polypoidal choroidal vasculopathy in Japanese patients: the APOLLO study","volume":"238","author":"Oshima","year":"2017","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2025.101414_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115587","article-title":"hPSC-based treatment of retinal diseases - current progress and challenges","volume":"221","author":"Ozaki","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.preteyeres.2025.101414_bib282","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101159","article-title":"Exploring the contribution of ARMS2 and HTRA1 genetic risk factors in age-related macular degeneration","volume":"97","author":"Pan","year":"2023","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101414_bib283","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000000331","article-title":"Pachychoroid neovasculopathy","volume":"35","author":"Pang","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib284","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10384-012-0119-6","article-title":"Polymorphisms in the VEGF-A in polypoidal choroidal vasculopathy in a Korean population","volume":"56","author":"Park","year":"2012","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib285","doi-asserted-by":"crossref","first-page":"e1579","DOI":"10.1111\/aos.15149","article-title":"Comparison of visual outcomes of polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration\u2014up to 10 years of follow-up","volume":"100","author":"Park","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib286","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/IAE.0000000000002234","article-title":"Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy secondary to chronic central serous chorioretinopathy","volume":"39","author":"Peiretti","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib287","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000439359","article-title":"Characteristics of neovascular age-related macular degeneration in Brazilian patients","volume":"234","author":"Pereira","year":"2015","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.preteyeres.2025.101414_bib288","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41433-023-02848-7","article-title":"Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-na\u00efve and anti-VEGF pretreated patients","volume":"38","author":"Pereira","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib289","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11113243","article-title":"Characterization of choroidal morphology and vasculature in the phenotype of pachychoroid diseases by swept-source OCT and OCTA","volume":"11","author":"Qiu","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib290","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/IAE.0000000000000875","article-title":"Efficacy of intravitreal injection of conbercept in polypoidal choroidal vasculopathy: subgroup analysis of the Aurora study","volume":"36","author":"Qu","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib291","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2147\/OPTH.S178228","article-title":"Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences","volume":"12","author":"Ratanasukon","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib292","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.6.6.4","article-title":"Polypoidal choroidal vasculopathy on swept-source optical coherence tomography angiography with variable Interscan time analysis","volume":"6","author":"Rebhun","year":"2017","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib293","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ophtha.2023.02.024","article-title":"Archway phase 3 trial of the port delivery system with ranibizumab for neovascular age-related macular degeneration 2-Year results","volume":"130","author":"Regillo","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib294","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4103\/ijo.IJO_174_17","article-title":"Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects","volume":"65","author":"Rishi","year":"2017","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib295","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1194\/jlr.R004820","article-title":"Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration","volume":"51","author":"Rodriguez","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.preteyeres.2025.101414_bib296","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archopht.120.4.502","article-title":"Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy","volume":"120","author":"Rosa","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib297","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/oxfordjournals.aje.a112252","article-title":"The estimation of synergy or antagonism","volume":"103","author":"Rothman","year":"1976","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib298","doi-asserted-by":"crossref","DOI":"10.3390\/genes15060720","article-title":"Gene therapy for non-hereditary retinal disease: age-related macular degeneration, diabetic retinopathy, and beyond","volume":"15","author":"Rowe","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.preteyeres.2025.101414_bib299","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2025.100144","article-title":"Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina society (APVRS)","volume":"14","author":"Ruamviboonsuk","year":"2025","journal-title":"Asia-Pacific Journal of Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib300","series-title":"Ryan's Retina E-Book","author":"Sadda","year":"2022"},{"key":"10.1016\/j.preteyeres.2025.101414_bib301","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/IAE.0b013e318156db60","article-title":"Cross-sectional and en face optical coherence tomographic features of polypoidal choroidal vasculopathy","volume":"28","author":"Saito","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib302","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajo.2008.02.007","article-title":"Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy","volume":"145","author":"Sakurada","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib303","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ophtha.2010.12.010","article-title":"Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy","volume":"118","author":"Sakurada","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib304","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000365487","article-title":"Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration","volume":"53","author":"Sakurada","year":"2015","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.preteyeres.2025.101414_bib305","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/OPTH.S54578","article-title":"One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy","volume":"8","author":"Sakurai","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib306","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1167\/iovs.11-7913","article-title":"Associations of IL-23 with polypoidal choroidal vasculopathy","volume":"53","author":"Sasaki","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib307","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.iae.0000249386.63482.05","article-title":"Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy","volume":"27","author":"Sato","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib308","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjophthalmol-2013-304658","article-title":"En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy","volume":"99","author":"Sayanagi","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib309","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s41598-024-52448-y","article-title":"Effect of polyp regression and reduction on treatment efficacy in polypoidal choroidal vasculopathy treated with aflibercept","volume":"14","author":"Sayanagi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/OPTH.S385827","article-title":"Polypoidal choroidal vasculopathy: an update on diagnosis and treatment","volume":"17","author":"Sen","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib311","article-title":"Evolution of polypoidal lesions after Anti-VEGF treatment using swept-source optical coherence tomography angiography in polypoidal choroidal vasculopathy","volume":"61","author":"Shen","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib312","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.991879","article-title":"Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"13","author":"Shen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib313","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ad2ca0","article-title":"DRFNet: a deep radiomic fusion network for nAMD\/PCV differentiation in OCT images","volume":"69","author":"Shen","year":"2024","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib314","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.4103\/ijo.IJO_2985_21","article-title":"Updated guidelines for the management of polypoidal choroidal vasculopathy: recommendations from the Indian polypoidal choroidal vasculopathy panel and the vitreoretinal society of India","volume":"70","author":"Sheth","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib315","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1111\/aos.15015","article-title":"Pachychoroid-phenotype effects on 5-year visual outcomes of anti-VEGF monotherapy in polypoidal choroidal vasculopathy","volume":"100","author":"Shimizu","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib316","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00417-015-2977-3","article-title":"Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration","volume":"253","author":"Shin","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib317","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41433-024-03373-x","article-title":"Exploring new Horizons in neovascular age-related macular degeneration: novel mechanisms of action and future therapeutic avenues","volume":"39","author":"Shirian","year":"2025","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib318","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40265-022-01713-3","article-title":"Faricimab: first approval","volume":"82","author":"Shirley","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.preteyeres.2025.101414_bib319","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","article-title":"Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics","volume":"121","author":"Sho","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib320","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.oret.2022.04.004","article-title":"Progression of pachychoroid neovasculopathy into aneurysmal type 1 choroidal neovascularization or polypoidal choroidal vasculopathy","volume":"6","author":"Siedlecki","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib321","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1038\/s41433-024-03318-4","article-title":"Pneumatic displacement of submacular haemorrhage secondary to neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"38","author":"Sim","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib322","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4103\/ijo.IJO_1757_18","article-title":"Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort","volume":"67","author":"Singh","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib323","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/1120672119850075","article-title":"Angiographic features of polypoidal choroidal vasculopathy using indocyanine green angiography and optical coherence tomography angiography: a comparative study","volume":"30","author":"Singh","year":"2020","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib324","doi-asserted-by":"crossref","first-page":"e1522","DOI":"10.1111\/aos.15148","article-title":"Clinical impact of the worldwide shortage of verteporfin (Visudyne\u00ae) on ophthalmic care","volume":"100","author":"Sirks","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/IAE.0000000000003921","article-title":"Risk of exudation in eyes with nonexudative polypoidal choroidal vasculopathy","volume":"44","author":"Son","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib326","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/aos.14295","article-title":"Plasma levels of inflammatory chemokines in patients with polypoidal choroidal vasculopathy","volume":"98","author":"S\u00f8rensen","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib327","doi-asserted-by":"crossref","DOI":"10.3390\/vision4020027","article-title":"Plasma levels of matrix metalloprotease MMP-9 and tissue inhibitor TIMP-1 in caucasian patients with polypoidal choroidal vasculopathy","volume":"4","author":"S\u00f8rensen","year":"2020","journal-title":"Vision"},{"key":"10.1016\/j.preteyeres.2025.101414_bib328","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/IAE.0000000000001689","article-title":"Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness","volume":"38","author":"Spaide","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib329","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/IAE.0000000000001732","article-title":"Improving the age-related macular degeneration construct: a new classification system","volume":"38","author":"Spaide","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib330","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib331","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","article-title":"Enhanced depth imaging spectral-domain optical coherence tomography","volume":"146","author":"Spaide","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib332","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib333","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1136\/bjophthalmol-2015-307892","article-title":"Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy","volume":"100","author":"Srour","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib334","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000514241","article-title":"Polypoidal choroidal vasculopathy after stereotactic radiotherapy for neovascular age-related macular degeneration: a case report with long-term Follow-Up","volume":"12","author":"Steinemann","year":"2021","journal-title":"Case Rep. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib335","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/IAE.0000000000003446","article-title":"Safety and therapeutic effects of orally administered AKST4290 in newly diagnosed neovascular age-related macular degeneration","volume":"42","author":"Stewart","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib336","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/13816810.2013.858753","article-title":"Three variants of or near VEGF-A gene are not associated with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in a Han Chinese population","volume":"36","author":"Su","year":"2015","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2025.101414_bib337","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1167\/iovs.17-22479","article-title":"CD11b and CD200 on circulating monocytes differentiate two angiographic subtypes of polypoidal choroidal vasculopathy","volume":"58","author":"Subhi","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib338","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.18632\/aging.101329","article-title":"T-cell differentiation and CD56+ levels in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration","volume":"9","author":"Subhi","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib339","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/jamaophthalmol.2019.0010","article-title":"Association of CD11b+ monocytes and anti-vascular endothelial growth factor injections in treatment of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"137","author":"Subhi","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib340","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/aos.13886","article-title":"Plasma markers of chronic low-grade inflammation in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration","volume":"97","author":"Subhi","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib341","first-page":"7147","article-title":"Cytokine profiling in patients with polypoidal choroidal vasculopathy before and after intravitreal injection of ranibizumab","volume":"14","author":"Sun","year":"2022","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.preteyeres.2025.101414_bib342","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.oret.2017.08.016","article-title":"Pachychoroid geographic atrophy: clinical and genetic characteristics","volume":"2","author":"Takahashi","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib343","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/eye.2016.232","article-title":"Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy","volume":"31","author":"Takayama","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib344","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/bjophthalmol-2014-305059","article-title":"A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes","volume":"98","author":"Tan","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib345","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bjophthalmol-2014-305674","article-title":"EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy","volume":"99","author":"Tan","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib346","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/IAE.0000000000003285","article-title":"Optical coherence tomography features of polypoidal lesion closure in polypoidal choroidal vasculopathy treated with aflibercept","volume":"42","author":"Tan","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib347","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1097\/IAE.0000000000003595","article-title":"Predictors and importance of complete polypoidal lesion regression in the EVEREST II study: predictors of polyp regression in polypoidal choroidal vasculopathy","volume":"42","author":"Tan","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib348","first-page":"2751","article-title":"Analysis of candidate genes for age-related macular degeneration subtypes in the Japanese population","volume":"17","author":"Tanaka","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2025.101414_bib349","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2415-14-83","article-title":"Associations of complement factor B and complement component 2 genotypes with subtypes of polypoidal choroidal vasculopathy","volume":"14","author":"Tanaka","year":"2014","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjophthalmol-2016-309264","article-title":"Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy","volume":"101","author":"Tanaka","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib351","first-page":"441","article-title":"Clinical characteristics of 254 cases of polypoidal choroidal vasculopathy","author":"Tao","year":"2012","journal-title":"Chinese Journal of Ocular Fundus Diseases"},{"key":"10.1016\/j.preteyeres.2025.101414_bib352","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092611","article-title":"The use of vascular endothelial growth factor inhibitors and complementary treatment options in polypoidal choroidal vasculopathy: a subtype of neovascular age-related macular degeneration","volume":"19","author":"Teo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib353","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/bjophthalmol-2020-318354","article-title":"Efficacy of a novel personalised aflibercept monotherapy regimen based on polypoidal lesion closure in participants with polypoidal choroidal vasculopathy","volume":"106","author":"Teo","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib354","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40123-024-00888-0","article-title":"Six-year outcomes in subjects with polypoidal choroidal vasculopathy in the EVEREST II study","volume":"13","author":"Teo","year":"2024","journal-title":"Ophthalmol. Ther"},{"key":"10.1016\/j.preteyeres.2025.101414_bib355","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1167\/iovs.18-25517","article-title":"Association of upregulated angiogenic cytokines with choroidal abnormalities in chronic central serous chorioretinopathy","volume":"59","author":"Terao","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib356","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jamaophthalmol.2022.2495","article-title":"Ranibizumab injection (Susvimo) implant septum dislodgement in a patient with neovascular age-related macular degeneration","volume":"140","author":"Timmons","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib357","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/ceo.12580","article-title":"Comparison of swept source optical coherence tomography and spectral domain optical coherence tomography in polypoidal choroidal vasculopathy","volume":"43","author":"Ting","year":"2015","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib358","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1167\/iovs.15-18898","article-title":"Characteristics of polypoidal choroidal vasculopathy evaluated by optical coherence tomography angiography","volume":"57","author":"Tomiyasu","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib359","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajo.2005.10.012","article-title":"Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization","volume":"141","author":"Tong","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib360","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/eye.2014.132","article-title":"Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy","volume":"28","author":"Toyama","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib361","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.11.2.6","article-title":"Diagnosis of polypoidal choroidal vasculopathy from fluorescein angiography using deep learning","volume":"11","author":"Tsai","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib362","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ajoc.2017.10.012","article-title":"Pathologic study of early manifestations of polypoidal choroidal vasculopathy and pathogenesis of choroidal neo-vascularization","volume":"11","author":"Tso","year":"2018","journal-title":"American Journal of Ophthalmology Case Reports"},{"key":"10.1016\/j.preteyeres.2025.101414_bib363","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/IAE.0b013e318150d864","article-title":"Retinal pigment epithelial tear in polypoidal choroidal vasculopathy","volume":"27","author":"Tsujikawa","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib364","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajo.2006.08.025","article-title":"Pigment epithelial detachment in polypoidal choroidal vasculopathy","volume":"143","author":"Tsujikawa","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib365","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1442-9071.2009.01907.x","article-title":"Macular polypoidal choroidal vasculopathy with a remote lesion","volume":"36","author":"Tsujikawa","year":"2008","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib366","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/archopht.117.8.1035","article-title":"Idiopathic polypoidal choroidal vasculopathy in Japanese patients","volume":"117","author":"Uyama","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib367","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0002-9394(02)01404-6","article-title":"Polypoidal choroidal vasculopathy: natural history","volume":"133","author":"Uyama","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib368","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101372","article-title":"Pachychoroid disease spectrum: how multimodal imaging and OCT angiography have improved our knowledge","volume":"107","author":"Viggiano","year":"2025","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101414_bib369","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bjo.2007.132357","article-title":"Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy","volume":"92","author":"Wakabayashi","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib370","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1167\/iovs.15-18955","article-title":"Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography","volume":"57","author":"Wang","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib371","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/IAE.0000000000001956","article-title":"Choroidal thickening and pachychoroid in cushing syndrome: correlation with endogenous cortisol level","volume":"39","author":"Wang","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib372","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4924053","article-title":"The efficacy of conbercept in polypoidal choroidal vasculopathy: a systematic review","volume":"2020","author":"Wang","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib373","article-title":"Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib374","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00417-023-06361-1","article-title":"Differences between young and elderly polypoidal choroidal vasculopathy patients with and without pachychoroid phenotypes","volume":"262","author":"Wang","year":"2024","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib375","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1111\/aos.16768","article-title":"Responsiveness of anti-VEGF treatment for polypoidal choroidal vasculopathy based on aqueous humour proteomics: a preliminary study","volume":"103","author":"Wang","year":"2025","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib376","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116902","article-title":"Advancements in age-related macular degeneration treatment: from traditional anti-VEGF to emerging therapies in gene, stem cell, and nanotechnology","volume":"236","author":"Wang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib377","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/IAE.0b013e3182953df4","article-title":"Pachychoroid pigment epitheliopathy","volume":"33","author":"Warrow","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib378","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229231","article-title":"Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy","volume":"15","author":"Wataru","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib379","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40360-019-0310-1","article-title":"One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy","volume":"20","author":"Weng","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib380","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/IAE.0000000000000499","article-title":"THREE-YEAR results of polypoidal choroidal vasculopathy treated with photodynamic therapy: Retrospective study and systematic review","volume":"35","author":"Wong","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib381","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajo.2019.02.027","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculopathy: two-year results of the aflibercept in polypoidal choroidal vasculopathy study","volume":"204","author":"Wong","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib382","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.11.10.16","article-title":"Application of deep learning for automated detection of polypoidal choroidal vasculopathy in spectral domain optical coherence tomography","volume":"11","author":"Wongchaisuwat","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib383","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132771","article-title":"Analysis of genetic and environmental risk factors and their interactions in Korean patients with age-related macular degeneration","volume":"10","author":"Woo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib384","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.21037\/qims-20-1027","article-title":"A modified measuring method to investigate the choriocapillaris flow void of polypoidal choroidal vasculopathy with swept source optical coherence tomography angiography","volume":"11","author":"Wu","year":"2021","journal-title":"Quant. Imag. Med. Surg."},{"key":"10.1016\/j.preteyeres.2025.101414_bib385","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/jamaophthalmol.2023.2421","article-title":"Effect of high-dose intravitreal aflibercept, 8 mg, in patients with neovascular age-related macular degeneration: the phase 2 CANDELA randomized clinical trial","volume":"141","author":"Wykoff","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.preteyeres.2025.101414_bib386","article-title":"KSI-501: a bispecific fusion protein antibody inhibiting both interleukin-6 and vascular endothelial growth factor. First-in human-trial results of multiple ascending doses in patients with diabetic macular edema","volume":"65","author":"Wykoff","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib387","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/diagnostics14010047","article-title":"The latest updates in swept-source optical coherence tomography angiography","volume":"14","author":"Xia","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.preteyeres.2025.101414_bib388","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13183017","article-title":"Factors influencing visual acuity in patients with active subfoveal circumscribed polypoidal choroidal vasculopathy and changes in imaging parameters","volume":"13","author":"Xia","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.preteyeres.2025.101414_bib389","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226763","article-title":"Associations of systemic, serum lipid and lipoprotein metabolic pathway gene variations with polypoidal choroidal vasculopathy in China","volume":"14","author":"Xu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib390","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bjophthalmol-2020-315817","article-title":"Automated diagnoses of age-related macular degeneration and polypoidal choroidal vasculopathy using bi-modal deep convolutional neural networks","volume":"105","author":"Xu","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib391","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/bjophthalmol-2016-310074","article-title":"Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians","volume":"101","author":"Yadav","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib392","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100201","article-title":"Natural course of pachychoroid pigment epitheliopathy","volume":"2","author":"Yagi","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.preteyeres.2025.101414_bib393","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.ophtha.2012.02.016","article-title":"Fundus autofluorescence in polypoidal choroidal vasculopathy","volume":"119","author":"Yamagishi","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib394","article-title":"Recurrent polypoidal choroidal vasculopathy after long-term Follow-Up of photodynamic therapy with verteporfin","volume":"49","author":"Yamamoto","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101414_bib395","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ophtha.2015.05.024","article-title":"One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy","volume":"122","author":"Yamamoto","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib396","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072034","article-title":"Characteristics of pachychoroid diseases and age-related macular degeneration: multimodal imaging and genetic backgrounds","volume":"9","author":"Yamashiro","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib397","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154614","article-title":"Relationship between pachychoroid and polypoidal choroidal vasculopathy","volume":"11","author":"Yamashiro","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib398","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ajo.2009.09.020","article-title":"One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy","volume":"149","author":"Yamashita","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib399","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10384-020-00740-5","article-title":"Pachychoroid disease: a new perspective on exudative maculopathy","volume":"64","author":"Yanagi","year":"2020","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib400","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/IAE.0000000000001758","article-title":"Choroidal vascular hyperpermeability as a predictor of treatment response for polypoidal choroidal vasculopathy","volume":"38","author":"Yanagi","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib401","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120643","article-title":"The association of elastin gene variants with two angiographic subtypes of polypoidal choroidal vasculopathy","volume":"10","author":"Yanagisawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101414_bib402","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000836","article-title":"Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degeneration","volume":"6","author":"Yang","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.preteyeres.2025.101414_bib403","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12886-019-1244-5","article-title":"Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy","volume":"19","author":"Yang","year":"2019","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib404","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00417-019-04493-x","article-title":"Utility of a public-available artificial intelligence in diagnosis of polypoidal choroidal vasculopathy","volume":"258","author":"Yang","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib406","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0161-6420(99)00173-6","article-title":"Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy","volume":"107","author":"Yannuzzi","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101414_bib407","article-title":"Associations of 6p21.3 region with age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"6","author":"Ye","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib408","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/IAE.0000000000001556","article-title":"Angiographic subtypes of polypoidal choroidal vasculopathy in taiwan: a prospective multicenter study","volume":"38","author":"Yeung","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib409","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41598-020-80731-1","article-title":"Comparison of visual outcomes between therapy choices and subtypes of polypoidal choroidal vasculopathy (PCV) in Taiwan: a real-world study","volume":"11","author":"Yeung","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101414_bib410","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/IAE.0000000000000964","article-title":"Genetic factors associated with choroidal vascular hyperpermeability and subfoveal choroidal thickness in polypoidal choroidal vasculopathy","volume":"36","author":"Yoneyama","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2025.101414_bib411","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12886-015-0064-5","article-title":"Photodynamic therapy versus anti-vascular endothelial growth factor agents for polypoidal choroidal vasculopathy: a meta-analysis","volume":"15","author":"Yong","year":"2015","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib412","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10384-013-0234-z","article-title":"Two-year results of reduced-fluence photodynamic therapy combined with intravitreal ranibizumab for typical age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"57","author":"Yoshida","year":"2013","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib413","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2025.101414_bib414","first-page":"200","article-title":"[Polypoidal choroidal vasculopathy]","volume":"116","author":"Yuzawa","year":"2012","journal-title":"Nippon. Ganka Gakkai Zasshi"},{"key":"10.1016\/j.preteyeres.2025.101414_bib415","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0021-5155(03)00042-X","article-title":"A study of laser photocoagulation for polypoidal choroidal vasculopathy","volume":"47","author":"Yuzawa","year":"2003","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib416","first-page":"729","article-title":"Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration","volume":"19","author":"Zeng","year":"2013","journal-title":"Mol. Vis."},{"key":"10.1016\/j.preteyeres.2025.101414_bib417","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00417-019-04445-5","article-title":"Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy","volume":"257","author":"Zhan","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib418","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41433-020-01265-4","article-title":"Drusen and pachydrusen: the definition, pathogenesis, and clinical significance","volume":"35","author":"Zhang","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib419","article-title":"Differentially regulated apolipoproteins and lipid profiles as novel biomarkers for polypoidal choroidal vasculopathy and neovascular age-related macular degeneration","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib420","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2393273","article-title":"Exploring and identifying the imaging biomarkers for predicting anti-VEGF treatment response in polypoidal choroidal vasculopathy: a prospective multicenter study","volume":"56","author":"Zhang","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib421","unstructured":"Zhao, C., Xia, C., Sun, Y., Li, C. MEDICAL PENETRATION DEVICE AND SYSTEM: WO2022\/237885 (A1) [P]. 2022-05-12."},{"key":"10.1016\/j.preteyeres.2025.101414_bib422","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00417-020-04977-1","article-title":"The polyp regression rate and treatment prognosis of different interventions for polypoidal choroidal vasculopathy: a systematic review and meta-analysis","volume":"259","author":"Zhao","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib423","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12886-019-1278-8","article-title":"Comparison of cytokine levels in the aqueous humor of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration patients","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101414_bib424","article-title":"Uveal effusion syndrome: clinical characteristics, outcome of surgical treatment, and histopathological examination of the sclera","volume":"9","author":"Zhou","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2025.101414_bib425","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40123-022-00618-4","article-title":"Determination of vascular endothelial growth Factor-B concentrations in aqueous humor and plasma of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy patients before and after Anti-VEGF therapy","volume":"12","author":"Zhou","year":"2023","journal-title":"Ophthalmology and therapy"},{"key":"10.1016\/j.preteyeres.2025.101414_bib426","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2025.100142","article-title":"Efficacy, durability and safety of faricimab for patients with neovascular age-related macular degeneration: 48-week results from the phase 3 LUCERNE China subpopulation","volume":"14","author":"Zou","year":"2025","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.preteyeres.2025.101414_bib427","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/13816810.2015.1107598","article-title":"ENOS polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in a Chinese Han population","volume":"37","author":"Zuo","year":"2016","journal-title":"Ophthalmic Genet."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946225000874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946225000874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:59:10Z","timestamp":1773871150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946225000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":427,"alternative-id":["S1350946225000874"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101414","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polypoidal choroidal vasculopathy: In-depth insights and promising future directions","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101414"}}